Today marks the early-bird release of the next-generation of CellCapTure (CCT) software. CCT 5.1 is the first of five exciting new products that Stratedigm will be launching by the end of 2022. CCT 5.1 now has even more functionality focusing on our built-in fully automated Uber Comp, optional Visual Protocol Designer (VPD), and A600 High Throughput Auto Sampler (HTAS). With […]

Department of Women’s and Children’s Health to Work with Fluidigm on CyTOF Research Applications, Product Development SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement with the Karolinska Institutet for research applications and product development utilizing […]

BUFFALO, N.Y  — KSL Biomedical, Inc., developers of novel diagnostic and therapeutic applications for immunology, oncology, virology, and genomics, announces expansion into Canada with the acquisition of Pulse Scientific, Inc. a diagnostic products manufacturer and distributor of medical, laboratory and research products located in Toronto. With the incorporation of KSL Biomedical Canada, Inc., and the […]

[Ames, Iowa ]  Skroot Laboratory, Inc. has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium of universities, companies, and clinical collaborators brought together to develop transformative tools and technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. The center, launched in […]

SINFONIA TECHNOLOGY CO., LTD. (Head office: Minato-ku, Tokyo; President: Fuminori Saito) has been developing a fully automated cell culture instrument in collaboration with the Foundation for Biomedical Research and Innovation at Kobe (FBRI; Locations: Kobe City, Hyogo Prefect.; President: Tasuku Honjo, M.D.,Ph.D.). With the successful results of demonstration experiments with human iPS cells and mesenchymal […]

The start up Celtarys Research, born at the University of Santiago de Compostela and dedicated to the development of fluorescent tools for drug discovery, has closed a seed capital investment round of 650,000 euros. In the round have participated the Galician institutional funds of the Xunta de Galicia – through XesGalicia – and VigoActivo, as […]

DUBAI – NanoCellect Biomedical Inc. a privately-held life sciences company, focused on developing microfluidic based cell analysis and sorting solutions, has signed an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka. Dr. Will Alaynick, Co-founder and Vice President International at NanoCellect […]

CAMBRIDGE, MA—Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the company’s tissue-chip platform for advanced studies of viral infection. With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies. The […]

BRANFORD, Conn. — IsoPlexis, a leader in functional single-cell proteomics, today announced the appointment of Dr. Jason Myers to its Board of Directors. Dr. Myers joins IsoPlexis’ Board of Directors with a wealth of experience in genomics, product development, and business leadership. Dr. Myers is the Chief Executive Officer at GenapSys, and a former board member of Invitae […]

MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pioneer and leader in the diagnostic industry, to its board of directors. “It is an honor to join the board of Akoya, a company that is providing innovative spatial biology solutions with […]